Full metadata record
DC FieldValueLanguage
dc.contributor.authorNijs, Jo-
dc.contributor.authorKosek, Eva-
dc.contributor.authorChiarotto, Alessandro-
dc.contributor.authorCook, Chad-
dc.contributor.authorHotz Boendermaker, Sabina-
dc.date.accessioned2024-03-09T18:00:38Z-
dc.date.available2024-03-09T18:00:38Z-
dc.date.issued2024-03-
dc.identifier.issn2665-9913de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/30151-
dc.description.abstractThe potential to classify low back pain as being characterised by dominant nociceptive, neuropathic, or nociplastic mechanisms is a clinically relevant issue. Preliminary evidence suggests that these low back pain phenotypes might respond differently to treatments; however, more research must be done before making specific recommendations. Accordingly, the low back pain phenotyping (BACPAP) consortium was established as a group of 36 clinicians and researchers from 13 countries (five continents) and 29 institutions, to apply a modified Nominal Group Technique methodology to develop international and multidisciplinary consensus recommendations to provide guidance for identifying the dominant pain phenotype in patients with low back pain, and potentially adapt pain management strategies. The BACPAP consortium's recommendations are also intended to provide direction for future clinical research by building on the established clinical criteria for neuropathic and nociplastic pain. The BACPAP consortium's consensus recommendations are a necessary early step in the process to determine if personalised pain medicine based on pain phenotypes is feasible for low back pain management. Therefore, these recommendations are not ready to be implemented in clinical practice until additional evidence is generated that is specific to these low back pain phenotypes.de_CH
dc.language.isoende_CH
dc.publisherElsevierde_CH
dc.relation.ispartofThe Lancet Rheumatologyde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subjectLow back painde_CH
dc.subjectNociplastic painde_CH
dc.subject.ddc617.5: Orthopädische Chirurgiede_CH
dc.titleNociceptive, neuropathic, or nociplastic low back pain? : the low back pain phenotyping (BACPAP) consortium's international and multidisciplinary consensus recommendationsde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementGesundheitde_CH
zhaw.organisationalunitInstitut für Physiotherapie (IPT)de_CH
dc.identifier.doi10.1016/S2665-9913(23)00324-7de_CH
zhaw.funding.euNode_CH
zhaw.issue3de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.endE188de_CH
zhaw.pages.startE178de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume6de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.author.additionalYesde_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen Gesundheit

Files in This Item:
There are no files associated with this item.
Show simple item record
Nijs, J., Kosek, E., Chiarotto, A., Cook, C., & Hotz Boendermaker, S. (2024). Nociceptive, neuropathic, or nociplastic low back pain? : the low back pain phenotyping (BACPAP) consortium’s international and multidisciplinary consensus recommendations. The Lancet Rheumatology, 6(3), E178–E188. https://doi.org/10.1016/S2665-9913(23)00324-7
Nijs, J. et al. (2024) ‘Nociceptive, neuropathic, or nociplastic low back pain? : the low back pain phenotyping (BACPAP) consortium’s international and multidisciplinary consensus recommendations’, The Lancet Rheumatology, 6(3), pp. E178–E188. Available at: https://doi.org/10.1016/S2665-9913(23)00324-7.
J. Nijs, E. Kosek, A. Chiarotto, C. Cook, and S. Hotz Boendermaker, “Nociceptive, neuropathic, or nociplastic low back pain? : the low back pain phenotyping (BACPAP) consortium’s international and multidisciplinary consensus recommendations,” The Lancet Rheumatology, vol. 6, no. 3, pp. E178–E188, Mar. 2024, doi: 10.1016/S2665-9913(23)00324-7.
NIJS, Jo, Eva KOSEK, Alessandro CHIAROTTO, Chad COOK und Sabina HOTZ BOENDERMAKER, 2024. Nociceptive, neuropathic, or nociplastic low back pain? : the low back pain phenotyping (BACPAP) consortium’s international and multidisciplinary consensus recommendations. The Lancet Rheumatology. März 2024. Bd. 6, Nr. 3, S. E178–E188. DOI 10.1016/S2665-9913(23)00324-7
Nijs, Jo, Eva Kosek, Alessandro Chiarotto, Chad Cook, and Sabina Hotz Boendermaker. 2024. “Nociceptive, Neuropathic, or Nociplastic Low Back Pain? : The Low Back Pain Phenotyping (BACPAP) Consortium’s International and Multidisciplinary Consensus Recommendations.” The Lancet Rheumatology 6 (3): E178–E88. https://doi.org/10.1016/S2665-9913(23)00324-7.
Nijs, Jo, et al. “Nociceptive, Neuropathic, or Nociplastic Low Back Pain? : The Low Back Pain Phenotyping (BACPAP) Consortium’s International and Multidisciplinary Consensus Recommendations.” The Lancet Rheumatology, vol. 6, no. 3, Mar. 2024, pp. E178–88, https://doi.org/10.1016/S2665-9913(23)00324-7.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.